{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-006471","form_type":"8-K","ticker":"ELTP","cik":"0001053369","company_name":"ELITE PHARMACEUTICALS INC /NV/","filed_at":"2025-02-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.817479+00:00","generated_at":"2026-05-26T21:56:17.024812+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Elite Pharma Q3 fiscal 2025 revenue $14.4M (-8% YoY); operating profit $1.1M (-69%)","bullets":["Consolidated revenue $14.4M for quarter ended Dec 31, 2024, down 8% from $15.6M in prior-year period.","Operating profit fell 69% to $1.1M from $3.5M; company cites year-end holiday shipment delays.","Shipments delayed into first week of January 2025 due to timing differences at December holiday period.","No EPS, net income, or updated guidance provided in the release; conference call scheduled Feb 14."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-006471","json":"https://secwatch.observer/filing/0001493152-25-006471.json","markdown":"https://secwatch.observer/filing/0001493152-25-006471.md","text":"https://secwatch.observer/filing/0001493152-25-006471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225006471/0001493152-25-006471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1053369/000149315225006471/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T21:56:17.024812+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}